Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

TRxADE HEALTH, Inc. (MEDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1300+0.0100 (+0.89%)
At close: 04:00PM EDT
1.1300 0.00 (0.00%)
After hours: 04:50PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.1200
Open1.1500
Bid1.0600 x 1800
Ask1.1500 x 1100
Day's Range1.0900 - 1.1800
52 Week Range1.0300 - 4.9500
Volume31,166
Avg. Volume538,701
Market Cap9.228M
Beta (5Y Monthly)1.24
PE Ratio (TTM)N/A
EPS (TTM)-0.8430
Earnings DateOct 24, 2022 - Oct 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.08
  • ACCESSWIRE

    Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal

    TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business subsidiary, has signed a Telemedicine Services Distribution Deal with Wakefern Food Corp., to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut, and Maryland.

  • GlobeNewswire

    TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program

    TAMPA, FL, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare marketplace platform that connects buyers and sellers, today announced the launch of the Trxade Prime Plus program via its pharmaceutical wholesale business subsidiary, Integra Pharma Solutions LLC (d/b/a TRxADE Prime), to allow its member pharmacies better access to over 20,000 pharmaceutical products available for next day delivery

  • ACCESSWIRE

    TRxADE HEALTH Announces Termination of Public Offering of Common Stock

    TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it has terminated the proposed underwritten public offering previously announced on August 23, 2022.

Advertisement
Advertisement